-
-
-
-
-
-
-
Evolus (EOLS) PT Lowered to $13 at BTIG
-
-
-
-
-
-
-
Mizuho on Evolus (EOLS): 'Medytox Selling Overhang Could End Soon', 'could enhance the stock's appeal to investors'
-
-
-
-
-
-
-
Evolus (EOLS) PT Lowered to $20 at H.C. Wainwright
-
-
-
-
-
-
-
Evolus (EOLS) Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
-
-
-
-
-
-
-
Evolus (EOLS) Misses Q4 EPS by 13c, Beats on Revenue; Offers FY25 Revenue Guidance
-
-
-
-
-
-
-
Evolus (EOLS) PT Raised to $25 at Mizuho
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/22: (TDC) (SKLZ) (XM) Higher; (EOLS) (NBSE) (FSR) Lower (more...)
414,362 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

